The world’s first Programmed cell death 1 (PD-1) inhibitor was approved in Japan this month for the treatment of advanced melanoma. This novel class of investigational immuno-oncology drugs continues to receive considerable attention and interest globally – particularly at this year’s annual… 520 more words